APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Agomelatine API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Agomelatine API Industry Growth and Trends Forecast to 2032

Report ID 173218420123 December 202578 pages

Choose your research edition.

Industry ResearchAgomelatine API Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Agomelatine API Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Agomelatine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Agomelatine API Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Agomelatine API Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Agomelatine API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Agomelatine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Agomelatine API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Agomelatine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Agomelatine API include Msn Pharmachem Private Ltd, Jiangsu Hansoh Pharmaceutical Group and Yangtze River Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Agomelatine API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Agomelatine API market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Agomelatine API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Agomelatine API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Agomelatine API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Agomelatine API Market by Company

Msn Pharmachem Private Ltd

Jiangsu Hansoh Pharmaceutical Group

Yangtze River Pharmaceutical

Agomelatine API Segment by Type

Purity ≥99%

98%≤purity≤99%

Agomelatine API Segment by Application

Tablets

Others

Agomelatine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Agomelatine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Agomelatine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Agomelatine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Agomelatine API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Agomelatine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity ≥99% Table 2. Major Company of 98%≤purity≤99% Table 3. Global Agomelatine API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Agomelatine API Sales by Type (2021-2026) & (Tons) Table 5. Global Agomelatine API Sales Market Share in Volume by Type (2021-2026) Table 6. Global Agomelatine API Sales by Type (2021-2026) & (US$ Million) Table 7. Global Agomelatine API Sales Market Share in Value by Type (2021-2026) Table 8. Global Agomelatine API Price by Type (2021-2026) & (US$/Ton) Table 9. Global Agomelatine API Sales by Type (2027-2032) & (Tons) Table 10. Global Agomelatine API Sales Market Share in Volume by Type (2027-2032) Table 11. Global Agomelatine API Sales by Type (2027-2032) & (US$ Million) Table 12. Global Agomelatine API Sales Market Share in Value by Type (2027-2032) Table 13. Global Agomelatine API Price by Type (2027-2032) & (US$/Ton) Table 14. North America Agomelatine API Sales by Type (2021-2026) & (Tons) Table 15. North America Agomelatine API Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Agomelatine API Sales by Type (2021-2026) & (Tons) Table 17. Europe Agomelatine API Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Agomelatine API Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Agomelatine API Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Agomelatine API Sales by Type (2021-2026) & (Tons) Table 21. Latin America Agomelatine API Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Agomelatine API Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Agomelatine API Sales by Type (2021-2026) & (US$ Million) Table 24. Agomelatine API Industry Trends Table 25. Agomelatine API Industry Drivers Table 26. Agomelatine API Industry Opportunities and Challenges Table 27. Agomelatine API Industry Restraints Table 28. Global Agomelatine API Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Agomelatine API Revenue Market Share by Company (2021-2026) Table 30. Global Agomelatine API Sales by Company (2021-2026) & (Tons) Table 31. Global Agomelatine API Sales Share by Company (2021-2026) Table 32. Global Agomelatine API Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Agomelatine API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Agomelatine API Major Company Production Sites and Headquarters Table 35. Global Agomelatine API Company, Product Type & Application Table 36. Global Agomelatine API Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Agomelatine API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Agomelatine API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Agomelatine API Sales by Region (2021-2026) & (Tons) Table 41. Global Agomelatine API Sales Market Share in Volume by Region (2021-2026) Table 42. Global Agomelatine API Sales by Region (2021-2026) & (US$ Million) Table 43. Global Agomelatine API Sales Market Share in Value by Region (2021-2026) Table 44. Global Agomelatine API Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Agomelatine API Sales by Region (2027-2032) & (Tons) Table 46. Global Agomelatine API Sales Market Share in Volume by Region (2027-2032) Table 47. Global Agomelatine API Sales by Region (2027-2032) & (US$ Million) Table 48. Global Agomelatine API Sales Market Share in Value by Region (2027-2032) Table 49. Global Agomelatine API Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Agomelatine API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Agomelatine API Sales by Application (2021-2026) & (Tons) Table 52. Global Agomelatine API Sales Market Share in Volume by Application (2021-2026) Table 53. Global Agomelatine API Sales by Application (2021-2026) & (US$ Million) Table 54. Global Agomelatine API Sales Market Share in Value by Application (2021-2026) Table 55. Global Agomelatine API Price by Application (2021-2026) & (US$/Ton) Table 56. Global Agomelatine API Sales by Application (2027-2032) & (Tons) Table 57. Global Agomelatine API Sales Market Share in Volume by Application (2027-2032) Table 58. Global Agomelatine API Sales by Application (2027-2032) & (US$ Million) Table 59. Global Agomelatine API Sales Market Share in Value by Application (2027-2032) Table 60. Global Agomelatine API Price by Application (2027-2032) & (US$/Ton) Table 61. North America Agomelatine API Sales by Application (2021-2026) & (Tons) Table 62. North America Agomelatine API Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Agomelatine API Sales by Application (2021-2026) & (Tons) Table 64. Europe Agomelatine API Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Agomelatine API Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Agomelatine API Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Agomelatine API Sales by Application (2021-2026) & (Tons) Table 68. Latin America Agomelatine API Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Agomelatine API Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Agomelatine API Sales by Application (2021-2026) & (US$ Million) Table 71. Msn Pharmachem Private Ltd Company Information Table 72. Msn Pharmachem Private Ltd Business Overview Table 73. Msn Pharmachem Private Ltd Agomelatine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Msn Pharmachem Private Ltd Agomelatine API Product Portfolio Table 75. Msn Pharmachem Private Ltd Recent Development Table 76. Jiangsu Hansoh Pharmaceutical Group Company Information Table 77. Jiangsu Hansoh Pharmaceutical Group Business Overview Table 78. Jiangsu Hansoh Pharmaceutical Group Agomelatine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Jiangsu Hansoh Pharmaceutical Group Agomelatine API Product Portfolio Table 80. Jiangsu Hansoh Pharmaceutical Group Recent Development Table 81. Yangtze River Pharmaceutical Company Information Table 82. Yangtze River Pharmaceutical Business Overview Table 83. Yangtze River Pharmaceutical Agomelatine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Yangtze River Pharmaceutical Agomelatine API Product Portfolio Table 85. Yangtze River Pharmaceutical Recent Development Table 86. North America Agomelatine API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 87. North America Agomelatine API Sales by Country (2021-2026) & (Tons) Table 88. North America Agomelatine API Sales Market Share by Country (2021-2026) Table 89. North America Agomelatine API Sales Forecast by Country (2027-2032) & (Tons) Table 90. North America Agomelatine API Sales Market Share Forecast by Country (2027-2032) Table 91. North America Agomelatine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Agomelatine API Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Agomelatine API Market Share by Country (2021-2026) Table 94. North America Agomelatine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Agomelatine API Market Share Forecast by Country (2027-2032) Table 96. Europe Agomelatine API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 97. Europe Agomelatine API Sales by Country (2021-2026) & (Tons) Table 98. Europe Agomelatine API Sales Market Share by Country (2021-2026) Table 99. Europe Agomelatine API Sales Forecast by Country (2027-2032) & (Tons) Table 100. Europe Agomelatine API Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Agomelatine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Agomelatine API Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Agomelatine API Market Share by Country (2021-2026) Table 104. Europe Agomelatine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Agomelatine API Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Agomelatine API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Agomelatine API Sales by Country (2021-2026) & (Tons) Table 108. Asia-Pacific Agomelatine API Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Agomelatine API Sales Forecast by Country (2027-2032) & (Tons) Table 110. Asia-Pacific Agomelatine API Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Agomelatine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Agomelatine API Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Agomelatine API Market Share by Country (2021-2026) Table 114. Asia-Pacific Agomelatine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Agomelatine API Market Share Forecast by Country (2027-2032) Table 116. Latin America Agomelatine API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 117. Latin America Agomelatine API Sales by Country (2021-2026) & (Tons) Table 118. Latin America Agomelatine API Sales Market Share by Country (2021-2026) Table 119. Latin America Agomelatine API Sales Forecast by Country (2027-2032) & (Tons) Table 120. Latin America Agomelatine API Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Agomelatine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Agomelatine API Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Agomelatine API Market Share by Country (2021-2026) Table 124. Latin America Agomelatine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Agomelatine API Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Agomelatine API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Agomelatine API Sales by Country (2021-2026) & (Tons) Table 128. Middle East and Africa Agomelatine API Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Agomelatine API Sales Forecast by Country (2027-2032) & (Tons) Table 130. Middle East and Africa Agomelatine API Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Agomelatine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Agomelatine API Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Agomelatine API Market Share by Country (2021-2026) Table 134. Middle East and Africa Agomelatine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Agomelatine API Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Agomelatine API Distributors List Table 139. Agomelatine API Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Agomelatine API Image Figure 2. Global Agomelatine API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Agomelatine API Market Size (2021-2032) & (US$ Million) Figure 4. Global Agomelatine API Sales (2021-2032) & (Tons) Figure 5. Purity ≥99% Image Figure 6. Global Purity ≥99% Sales YoY Growth (2021-2032) & (Tons) Figure 7. 98%≤purity≤99% Image Figure 8. Global 98%≤purity≤99% Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Agomelatine API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Agomelatine API Market Share by Type 2025 VS 2032 Figure 11. North America Agomelatine API Sales Market Share in Volume by Type in 2025 Figure 12. North America Agomelatine API Sales Market Share in Value by Type in 2025 Figure 13. Europe Agomelatine API Sales Market Share in Volume by Type in 2025 Figure 14. Europe Agomelatine API Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Agomelatine API Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Agomelatine API Sales Market Share in Value by Type in 2025 Figure 17. Latin America Agomelatine API Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Agomelatine API Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Agomelatine API Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Agomelatine API Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Agomelatine API Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Tablets Image Figure 24. Global Tablets Sales YoY Growth (2021-2032) & (Tons) Figure 25. Others Image Figure 26. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 27. Global Agomelatine API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Agomelatine API Market Share by Application 2025 VS 2032 Figure 29. North America Agomelatine API Sales Market Share in Volume by Application in 2025 Figure 30. North America Agomelatine API Sales Market Share in Value by Application in 2025 Figure 31. Europe Agomelatine API Sales Market Share in Volume by Application in 2025 Figure 32. Europe Agomelatine API Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Agomelatine API Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Agomelatine API Sales Market Share in Value by Application in 2025 Figure 35. Latin America Agomelatine API Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Agomelatine API Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Agomelatine API Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Agomelatine API Sales Market Share in Value by Application in 2025 Figure 39. North America Agomelatine API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 40. North America Agomelatine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Agomelatine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Agomelatine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Agomelatine API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. Europe Agomelatine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Agomelatine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Agomelatine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Agomelatine API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Asia-Pacific Agomelatine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Agomelatine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Agomelatine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Agomelatine API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Latin America Agomelatine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Agomelatine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Agomelatine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Agomelatine API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Middle East and Africa Agomelatine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Agomelatine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Agomelatine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Agomelatine API Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Agomelatine API Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥99%
  • 98%≤purity≤99%
Applications
  • Tablets
  • Others
Companies covered
  • Msn Pharmachem Private Ltd
  • Jiangsu Hansoh Pharmaceutical Group
  • Yangtze River Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Agomelatine API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Agomelatine API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Agomelatine API Market by Type
  6. 1.3.1 Purity ≥99%
  7. 1.3.2 98%≤purity≤99%
  8. 1.4 Global Agomelatine API Market Size by Type
  9. 1.4.1 Global Agomelatine API Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Agomelatine API Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Agomelatine API Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Agomelatine API Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Agomelatine API Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Agomelatine API Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Agomelatine API Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Agomelatine API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Agomelatine API Industry Trends
  2. 2.2 Agomelatine API Industry Drivers
  3. 2.3 Agomelatine API Industry Opportunities and Challenges
  4. 2.4 Agomelatine API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Agomelatine API Revenue (2021-2026)
  2. 3.2 Global Top Players by Agomelatine API Sales (2021-2026)
  3. 3.3 Global Top Players by Agomelatine API Price (2021-2026)
  4. 3.4 Global Agomelatine API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Agomelatine API Major Company Production Sites & Headquarters
  6. 3.6 Global Agomelatine API Company, Product Type & Application
  7. 3.7 Global Agomelatine API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Agomelatine API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Agomelatine API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Agomelatine API Tier 1, Tier 2, and Tier 3
4 Agomelatine API Regional Status and Outlook
  1. 4.1 Global Agomelatine API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Agomelatine API Historic Market Size by Region
  3. 4.2.1 Global Agomelatine API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Agomelatine API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Agomelatine API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Agomelatine API Forecasted Market Size by Region
  7. 4.3.1 Global Agomelatine API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Agomelatine API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Agomelatine API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Agomelatine API by Application
  1. 5.1 Agomelatine API Market by Application
  2. 5.1.1 Tablets
  3. 5.1.2 Others
  4. 5.2 Global Agomelatine API Market Size by Application
  5. 5.2.1 Global Agomelatine API Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Agomelatine API Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Agomelatine API Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Agomelatine API Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Agomelatine API Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Agomelatine API Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Agomelatine API Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Agomelatine API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Msn Pharmachem Private Ltd
  2. 6.1.1 Msn Pharmachem Private Ltd Company Information
  3. 6.1.2 Msn Pharmachem Private Ltd Business Overview
  4. 6.1.3 Msn Pharmachem Private Ltd Agomelatine API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Msn Pharmachem Private Ltd Agomelatine API Product Portfolio
  6. 6.1.5 Msn Pharmachem Private Ltd Recent Developments
  7. 6.2 Jiangsu Hansoh Pharmaceutical Group
  8. 6.2.1 Jiangsu Hansoh Pharmaceutical Group Company Information
  9. 6.2.2 Jiangsu Hansoh Pharmaceutical Group Business Overview
  10. 6.2.3 Jiangsu Hansoh Pharmaceutical Group Agomelatine API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Jiangsu Hansoh Pharmaceutical Group Agomelatine API Product Portfolio
  12. 6.2.5 Jiangsu Hansoh Pharmaceutical Group Recent Developments
  13. 6.3 Yangtze River Pharmaceutical
  14. 6.3.1 Yangtze River Pharmaceutical Company Information
  15. 6.3.2 Yangtze River Pharmaceutical Business Overview
  16. 6.3.3 Yangtze River Pharmaceutical Agomelatine API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Yangtze River Pharmaceutical Agomelatine API Product Portfolio
  18. 6.3.5 Yangtze River Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Agomelatine API Sales by Country
  2. 7.1.1 North America Agomelatine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Agomelatine API Sales by Country (2021-2026)
  4. 7.1.3 North America Agomelatine API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Agomelatine API Market Size by Country
  6. 7.2.1 North America Agomelatine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Agomelatine API Market Size by Country (2021-2026)
  8. 7.2.3 North America Agomelatine API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Agomelatine API Sales by Country
  2. 8.1.1 Europe Agomelatine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Agomelatine API Sales by Country (2021-2026)
  4. 8.1.3 Europe Agomelatine API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Agomelatine API Market Size by Country
  6. 8.2.1 Europe Agomelatine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Agomelatine API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Agomelatine API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Agomelatine API Sales by Country
  2. 9.1.1 Asia-Pacific Agomelatine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Agomelatine API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Agomelatine API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Agomelatine API Market Size by Country
  6. 9.2.1 Asia-Pacific Agomelatine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Agomelatine API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Agomelatine API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Agomelatine API Sales by Country
  2. 10.1.1 South America Agomelatine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Agomelatine API Sales by Country (2021-2026)
  4. 10.1.3 South America Agomelatine API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Agomelatine API Market Size by Country
  6. 10.2.1 South America Agomelatine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Agomelatine API Market Size by Country (2021-2026)
  8. 10.2.3 South America Agomelatine API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Agomelatine API Sales by Country
  2. 11.1.1 Middle East and Africa Agomelatine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Agomelatine API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Agomelatine API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Agomelatine API Market Size by Country
  6. 11.2.1 Middle East and Africa Agomelatine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Agomelatine API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Agomelatine API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Agomelatine API Value Chain Analysis
  2. 12.1.1 Agomelatine API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Agomelatine API Production Mode & Process
  7. 12.2 Agomelatine API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Agomelatine API Distributors
  10. 12.2.3 Agomelatine API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst